Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lipman

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 17, 2002
Tuberculosis in primary careSurinder Singh, Sara Madge, Marc Lipman
Expert Review of Anti-Infective Therapy|November 13, 2015
Personalizing therapy for multidrug resistant TB: the potential of Rapid Whole Genome SequencingJosephine M Bryant, Marc Lipman, Judith Breuer
Annals of Clinical Microbiology and Antimicrobials|February 21, 2023
The roles of neutrophils in non-tuberculous mycobacterial pulmonary diseaseMeyad Alkarni, Marc Lipman, David M Lowe
The Journal of Infection|January 13, 2006
Pneumocystis pneumonia revisited: delayed diagnosis in an HIV infected individual with high blood and low lung CD4 T cell countsBen Killingley, Ronan Breen, Marc Lipman, et al.
BMJ Case Reports|November 22, 2013
Carcinoid tumour presenting as recurrent pneumoniaRuvini Dharmagunawardena, Marc Lipman, Joanne Cleverley, et al.
Frontiers in Microbiology|December 16, 2022
Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteriaPriya Solanki, Marc Lipman, Timothy D McHugh, et al.
The Lancet. Infectious Diseases|March 6, 2019
Revolutionary new treatment regimens for multidrug-resistant tuberculosisTimothy D McHugh, Isobella Honeyborne, Marc Lipman, et al.
BMC Medicine|March 24, 2016
Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatmentIbrahim Abubakar, Marc Lipman, Timothy D McHugh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 19, 2019
The changing treatment landscape for MDR/XDR-TB - Can current clinical trials revolutionise and inform a brave new world?Isobella Honeyborne, Marc Lipman, Alimuddin Zumla, et al.
Annals of Clinical Microbiology and Antimicrobials|May 25, 2020
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmesToyin Togun, Beate Kampmann, Neil Graham Stoker, et al.
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 17, 2002
Tuberculosis in primary careSurinder Singh, Sara Madge, Marc Lipman
Expert Review of Anti-Infective Therapy|November 13, 2015
Personalizing therapy for multidrug resistant TB: the potential of Rapid Whole Genome SequencingJosephine M Bryant, Marc Lipman, Judith Breuer
Annals of Clinical Microbiology and Antimicrobials|February 21, 2023
The roles of neutrophils in non-tuberculous mycobacterial pulmonary diseaseMeyad Alkarni, Marc Lipman, David M Lowe
The Journal of Infection|January 13, 2006
Pneumocystis pneumonia revisited: delayed diagnosis in an HIV infected individual with high blood and low lung CD4 T cell countsBen Killingley, Ronan Breen, Marc Lipman, et al.
BMJ Case Reports|November 22, 2013
Carcinoid tumour presenting as recurrent pneumoniaRuvini Dharmagunawardena, Marc Lipman, Joanne Cleverley, et al.
Frontiers in Microbiology|December 16, 2022
Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteriaPriya Solanki, Marc Lipman, Timothy D McHugh, et al.
The Lancet. Infectious Diseases|March 6, 2019
Revolutionary new treatment regimens for multidrug-resistant tuberculosisTimothy D McHugh, Isobella Honeyborne, Marc Lipman, et al.
BMC Medicine|March 24, 2016
Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatmentIbrahim Abubakar, Marc Lipman, Timothy D McHugh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 19, 2019
The changing treatment landscape for MDR/XDR-TB - Can current clinical trials revolutionise and inform a brave new world?Isobella Honeyborne, Marc Lipman, Alimuddin Zumla, et al.
Annals of Clinical Microbiology and Antimicrobials|May 25, 2020
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmesToyin Togun, Beate Kampmann, Neil Graham Stoker, et al.
Pageof 19